Filter
622
Text search:
American
Diabetes
Association
Featured
Recommendations
46
New Publications
110
Language
Document type
No document type
317
Studies & Reports
138
Guidelines
109
Manuals
25
Strategic & Response Plan
15
Training Material
7
Fact sheets
7
Situation Updates
2
App
1
Infographics
1
Countries / Regions
Global
41
India
31
Latin America and the Carribbean
20
Indonesia
18
Brazil
18
Philippines
16
South Africa
10
Western and Central Europe
10
Kenya
8
Bangladesh
8
Ethiopia
6
Venezuela
6
Nigeria
5
USA
5
Tanzania
5
Chile
5
Africa
5
Ghana
4
Nepal
4
Zambia
4
Syria
4
Cambodia
4
Argentina
4
Ecuador
4
Paraguay
4
Eastern Europe
4
North America
4
Uganda
3
Germany
3
Rwanda
3
Mozambique
3
Namibia
3
Eswatini/ Swaziland
3
South–East Asia Region
3
Russia
3
Sierra Leone
2
Liberia
2
Cameroon
2
Malawi
2
Peru
2
Ukraine
2
Colombia
2
Angola
2
Myanmar / Burma
2
East and Southern Africa
2
Asia
2
Guinea
1
Congo, Democratic Republic of
1
Guinea-Bissau
1
Zimbabwe
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Thailand
1
China
1
Benin
1
Botswana
1
Lesotho
1
Mexico
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Other region
1
Canada
1
Kyrgyzstan
1
Jamaica
1
United Kingdom
1
Portugal
1
Spain
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
194
Clinical Guidelines
93
Public Health
79
Women & Child Health
26
Key Resources
12
Capacity Building
4
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
Mental Health
90
NCDs
75
COVID-19
55
TB
38
Caregiver
23
Planetary Health
23
HIV
19
Disability
18
Global Health Education
15
Pharmacy
13
Refugee
12
NTDs
10
Conflict
7
Rapid Response
6
AMR
6
Health Financing Toolbox
6
Natural Hazards
2
Zika
2
Ebola & Marburg
1
Cholera
1
Specific Hazards
1
Social Ethics
1
2.0 Rapid Response
1
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm
...
В борьбе с туберкулезом достигнуты значительные прорывы, среди которых ускоренные и более точные методы диагностики и первые новые лекарственные средства за 50 л
...
The global burden of disease associated with air pollution exposure exacts a massive toll on human health worldwide: exposure to air pollution is estimated to cause millions of deaths and lost years of healthy life annually. The burden of disease attributable to air pollution is now estimated to be
...
The article discusses the significant impact of chronic obstructive pulmonary disease (COPD) as a global health issue, with cigarette smoking as the main risk factor. However, in developing countries, the causes of COPD are often multifactorial, involving environmental tobacco smoke, biomass fuel sm
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau
...
Policy Research Working Paper 6100 | Impact Evaluation Series No. 60 | This study examines the effect of performance incentives for health care providers to provide more and higher quality care in Rwanda on child health outcomes. The authors find that the incentives had a large and significant effec
...
Prescriptions and Actionables for a Healthy and Green Recovery.
The practical steps outlined in this report aim at creating a healthier, fairer and greener world while investing to maintain and resuscitate the economy hit by the effects of COVID-19.
Policy makers, national and local decision-make
...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im
...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE
...
This Birth Defect Surveillance facilitator (train-the-trainer) guide 2nd edition covers foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomaly surveillance programme, whether population-based or hospital-based, in particular for countries
...
5th edition.
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
En 2015, murieron 5,9 millones de niños menores de cinco años (1). Las principales causas de muerte en los niños a nivel mundial son la neumonía, la prematuridad, las complicaciones durante el parto, la sepsis neonatal, las anomalías congénitas, las enfermedades diarreicas, las lesiones
...
